Silvio E Inzucchi

Hyperglycaemia and its therapy during acute coronary syndromes
Diab Vasc Dis Res 2008 5: 259. [PDF] [Request Permission]  

Antonio Ceriello

Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings
Diab Vasc Dis Res 2008 5: 260-268. [Abstract] [PDF] [References] [Request Permission]  

Mikhail Kosiborod

Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction
Diab Vasc Dis Res 2008 5: 269-275. [Abstract] [PDF] [References] [Request Permission]  

Abhinav Goyal, Kara Nerenberg, Hertzel C Gerstein, Guillermo Umpierrez, and Peter WF Wilson

Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points
Diab Vasc Dis Res 2008 5: 276-284. [Abstract] [PDF] [References] [Request Permission]  

Matteo Anselmino, Märit Wallander, Anna Norhammar, Linda Mellbin, and Lars Rydén

Implications of abnormal glucose metabolism in patients with coronary artery disease
Diab Vasc Dis Res 2008 5: 285-290. [Abstract] [PDF] [References] [Request Permission]  

Maria Wany Louzada Strufaldi, Edina Mariko Koga Da Silva, and Rosana Fiorini Puccini

Metabolic syndrome among prepubertal Brazilian schoolchildren
Diab Vasc Dis Res 2008 5: 291-297. [Abstract] [PDF] [References] [Request Permission]  

Thomas Forst, Birgit Wilhelm, Andreas Pfützner, Winfried Fuchs, Ute Lehmann, Frank Schaper, Matthias Weber, Jürgen Müller, Thomas Konrad, and Markolf Hanefeld

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk
Diab Vasc Dis Res 2008 5: 298-303. [Abstract] [PDF] [References] [Request Permission]  

Jawad A Al-Lawati, Nabil M Barakat, Alya M Al-Lawati, and Ali J Mohammed

Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East
Diab Vasc Dis Res 2008 5: 304-309. [Abstract] [PDF] [References] [Request Permission]  

Helene Von Bibra, Michaela Diamant, Peter G Scheffer, Thorsten Siegmund, and Petra-Maria Schumm-Draeger

Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
Diab Vasc Dis Res 2008 5: 310-318. [Abstract] [PDF] [References] [Request Permission]  

Jean-Charles Fruchart, Frank M Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown, Richard Ceska, M John Chapman, Paul M Dodson, Paola Fioretto, Henry N Ginsberg, Takashi Kadowaki, Jean-Marc Lablanche, Nikolaus Marx, Jorge Plutzky, Zeljko Reiner, Robert S Rosenson, Bart Staels, Jane K Stock, Rody Sy, Christoph Wanner, Alberto Zambon, and Paul Zimmet

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Diab Vasc Dis Res 2008 5: 319-335. [Abstract] [PDF] [References] [Request Permission]  

Martin Schönauer, Andreas Thomas, Stephan Morbach, Josef Niebauer, Ulrike Schönauer, and Holger Thiele

Cardiac autonomic diabetic neuropathy
Diab Vasc Dis Res 2008 5: 336-344. [Abstract] [PDF] [References] [Request Permission]  

Nikolaus Marx

PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetes
Diab Vasc Dis Res 2008 5: 345-346. [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.